Cargando…

Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States

BACKGROUND: Despite multiple treatment options, the prognosis of pulmonary arterial hypertension (PAH) remains poor. PAH patients experience a high economic burden due to comorbidities, hospitalizations, and medication costs. Although combination therapy has been shown to reduce hospitalizations, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burger, Charles D., Ozbay, A. Burak, Lazarus, Howard M., Riehle, Ellen, Montejano, Leslie B., Lenhart, Gregory, White, R. James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398102/ https://www.ncbi.nlm.nih.gov/pubmed/29436260 http://dx.doi.org/10.18553/jmcp.2018.17391

Ejemplares similares

Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence
por: Galaznik, Aaron, et al.
Publicado: (2014)

Initial Costs of Ebola Treatment Centers in the United States
por: Herstein, Jocelyn J., et al.
Publicado: (2016)

Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
por: Matias, Wilfredo R, et al.
Publicado: (2022)

Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -
por: Klora, Mike, et al.
Publicado: (2015)

Direct Costs of Hypertension Treatment in Iran
por: Zamandi, Mahmoud, et al.
Publicado: (2023)

Health care costs in US patients with and without a diagnosis of osteoarthritis
por: Le, T Kim, et al.
Publicado: (2012)

Real‐world treatment patterns, healthcare resource utilization, and cost among adults with pulmonary arterial hypertension in the United States
por: Pizzicato, Lia N., et al.
Publicado: (2022)

Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives
por: Miller, Jeffrey D., et al.
Publicado: (2015)

Drug Use before and after Initiating Treatment with Acetylcholinesterase Inhibitors
por: Efjestad, Anne Sverdrup, et al.
Publicado: (2019)

Timeliness of antiretroviral therapy initiation in the era before universal treatment
por: Bogdanić, Nikolina, et al.
Publicado: (2021)

Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension
por: Dong, Wenxing, et al.
Publicado: (2023)

A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2)
por: Lazarus, Howard M., et al.
Publicado: (2022)

EE410 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Three Countries of LATAM: Argentina, Chile, and Colombia
por: Montejano, R, et al.
Publicado: (2022)

Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs
por: Bonafede, Machaon M, et al.
Publicado: (2014)

Severe fatigue and related factors in cancer patients before the initiation of treatment
por: Goedendorp, M M, et al.
Publicado: (2008)

Cost Trend Analysis of Initial Cancer Treatment in Taiwan
por: Li, Tsai-Yun, et al.
Publicado: (2014)

Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan
por: Tamura, Yuichi, et al.
Publicado: (2022)

Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany
por: Canbay, Ali, et al.
Publicado: (2021)

Prognosis of pulmonary arterial hypertension patients with pericardial effusion before and after initiation of parenteral prostacyclin therapy
por: Abu‐Rmaileh, Muhammad, et al.
Publicado: (2023)

Comparing Diagnosis and Treatment of Pulmonary Hypertension Patients at a Pulmonary Hypertension Center versus Community Centers
por: Saunders, Hollie, et al.
Publicado: (2022)

Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
por: Pesa, Jacqueline A., et al.
Publicado: (2015)

Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program
por: Rosendaal, Nicole T. A., et al.
Publicado: (2016)

Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score
por: Gordon, Stuart C., et al.
Publicado: (2020)

Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen
por: Vidovic, Maximilian, et al.
Publicado: (2023)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Current trends in treatment of hypertension in Karachi and cost minimization possibilities
por: Hussain, Izhar M., et al.
Publicado: (2015)

Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States
por: Dempsey, Timothy M., et al.
Publicado: (2022)

Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
por: Winston, Carla A., et al.
Publicado: (2023)

A comparative cost analysis before and after opening of an intermediate care unit
por: Solberg, B, et al.
Publicado: (2005)

Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States
por: Dixon, Dave L., et al.
Publicado: (2023)

Cost-Effectiveness of Community-Based Tobacco Dependence Treatment Interventions: Initial Findings of a Systematic Review
por: Reisinger, Sarah A., et al.
Publicado: (2019)

Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2010)

Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases
por: Wong, Robert J., et al.
Publicado: (2021)

Treatment of pulmonary hypertension
por: Patel, Rajendrakumar, et al.
Publicado: (2012)

Treatment of pulmonary hypertension
por: Tagliabue, Paolo, et al.
Publicado: (2014)

Use of Biologic Therapies in the Treatment of Asthma – A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation
por: Hardtstock, Fraence, et al.
Publicado: (2022)

Correction: Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program
Publicado: (2016)

Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives
por: Miller, Jeffrey D, et al.
Publicado: (2015)

Right Ventricular Postsystolic Strain Curve Morphology before and after Vasodilator Treatment in Idiopathic Pulmonary Arterial Hypertension
por: Rodríguez-Pérez, Álvaro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u4n9fo5dqhd3nl34t30qrebvud